Quantcast
Viewing all articles
Browse latest Browse all 3128

GSK terminates Phase 2 trial of HBV therapeutic vaccine

GSK has axed a Phase 2 study of a chronic hepatitis B therapeutic vaccine, adding to a string of treatment R&D hurdles for the liver infection. The termination of the study of GSK3528869 was the ...

Viewing all articles
Browse latest Browse all 3128

Trending Articles